ImmBio (AgeTech UK) Covid-19

Innovative vaccines. ImmBio is developing next-generation vaccines against serious infectious disease targets, utilising its proprietary technology platforms to directly induce immunity via dendritic cells.
Technology: AgeTech Companies
Industry: UK AgeTech 2020
Headquarters: United Kingdom
Founded Date: N/A
Employees Number: N/A
Funding Status: N/A

Visit Website
Register and Claim Ownership